Avita Medical | 1811094D - Pre Tax Profit


Avita Medical reported AUD-11.64M in Pre-Tax Profit for its fiscal semester ending in December of 2025.





Pre Tax Profit Change Date
Accuray USD 3.23M 6.56M Dec/2024
Celltrion KRW 11.84B 1.34B Mar/2026
Clinuvel Pharmaceuticals AUD 28.8M 6.9M Jun/2025
Cochlear AUD 121.1M 155.6M Jun/2025
CSL USD 2.61B 1.21B Dec/2025
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 11.8B 2.17B Jun/2026
Kangmei Pharma CNY -14.01M 16.08M Mar/2026
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Mayne Pharma AUD -14.7M 42.91M Dec/2024
Medical Developments International AUD -149K 466K Jun/2025
Nanosonics AUD 11.39M 487K Jun/2025
Neuren Pharmaceuticals AUD 19.21M 9.35M Dec/2025
Organigram Holdings CAD -921K 40.8M Mar/2026
Pacific Edge NZD -714K 49K Mar/2024
Pharma Mar EUR -993K 2.59M Jun/2026
Polynovo AUD 1.96M 146K Dec/2025
PYC Therapeutics AUD -12.57M 13.3M Jun/2025
Qiagen NV USD 85.83M 23.34M Mar/2026
Ramsay Health Care AUD 240.5M 136.75M Dec/2025
ResMed USD 502.31M 6.16M Mar/2026
Sartorius EUR 127M 30.8M Jun/2026
Telix Pharmaceuticals AUD 76.73M 66.04M Jun/2025
Tilray USD -39.96M 39.19M Sep/2025
Zealand Pharma A/S -394M 12.5M Mar/2026
Zz Pientze Pharmaceu CNY 876.07M 352.96M Mar/2026